Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study.

Background: There is scarce data on CASR associations with dyslipidemia. We investigated in hemodialysis (HD) patients whether CASR single nucleotide polymorphisms (SNPs) rs7652589 and rs1801725 have associations with dyslipidemia and show epistatic interactions with SNPs of the energy homeostasis-a...

Full description

Bibliographic Details
Published in:BMC Nephrology Vol. 20; no. 1; pp. 1 - 10
Main Authors: Grzegorzewska, Alicja E., Frycz, Bartosz A., Świderska, Monika, Niepolski, Leszek, Mostowska, Adrianna, Jagodziński, Paweł P.
Format: research Journal Article
Published: BioMed Central 11/27/2019
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139892785&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139892785
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14712369
        1CI6
      jtl: BMC Nephrology
      issn: 14712369
      maglogo: N
    pubinfo:
      dt: 11/27/2019
      vid: 20
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        139892785
        139892785
        NLM31775661
        139892785
        10.1186/s12882-019-1619-0
        NLM31775661
        139892785
      ppf: 1
      ppct: 9
      formats:
      tig:
        atl: Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study.
      aug:
        au:
          Grzegorzewska, Alicja E.
          Frycz, Bartosz A.
          Świderska, Monika
          Niepolski, Leszek
          Mostowska, Adrianna
          Jagodziński, Paweł P.
        affil: Department of Nephrology, Transplantology and Internal Diseases, Poznan University of Medical Sciences, Przybyszewskiego 49, 60-355, Poznań, Poland
      sug:
        subj:
          Kidney Failure, Chronic Epidemiology
          Hemodialysis Adverse Effects
          Kidney Failure, Chronic Therapy
          Hemodialysis Methods
          Kidney Failure, Chronic Metabolism
          Hyperlipidemia
          Calcium Binding Proteins
          Calcium Binding Proteins Metabolism
          Polymorphism, Genetic
          Aged
          Middle Age
          Cross Sectional Studies
          Intercellular Signaling Peptides and Proteins
          Male
          Gene Expression Profiling Methods
          Proteins
          Human
          Poland
          Female
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Aged: 65+ years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background: There is scarce data on CASR associations with dyslipidemia. We investigated in hemodialysis (HD) patients whether CASR single nucleotide polymorphisms (SNPs) rs7652589 and rs1801725 have associations with dyslipidemia and show epistatic interactions with SNPs of the energy homeostasis-associated gene (ENHO), retinoid X receptor α gene (RXRA), and liver X receptor α gene (LXRA).Methods: The study included 1208 HD subjects. For diagnosis of dyslipidemia, both K/DOQI criteria and atherogenic index ≥3.8 were used. CASR rs1801725 was genotyped by TaqMan SNP Genotyping Assay, other SNPs - by high-resolution melting curve analysis or polymerase chain reaction-restriction fragment length polymorphism, as appropriate. Relative transcript levels of CASR, ENHO, RXRA, and LXRA were measured in peripheral blood mononuclear cells. The occurrence of dyslipidemic phenotypes concerning tested polymorphisms was compared using models of inheritance. Haplotypes were estimated using the Haploview 4.2 software. Epistatic interactions between tested SNPs were analyzed using the logistic regression and epistasis option in the PLINK software.Results: Rs7652589 indicated a greater probability of atherogenic dyslipidemia in the dominant inheritance model (OR 1.4, 95%CI 1.0-2.0, P = 0.026), principally because of increased triglyceride (TG) levels. The rs1801725 variant allele was associated with a decreased probability of dyslipidemia characterized by non-HDL-cholesterol ≥130 mg/dL and TG ≥200 mg/dL (OR 0.6, 0.4-0.9, P = 0.012). There were no epistatic interactions between CASR and RXRA, LXRA, and ENHO regarding dyslipidemia. Both rs7652589 and rs1801725 SNPs were not in linkage disequilibrium (D' = 0.091, r2 = 0.003 for the entire HD group) and their haplotypes did not correlate with dyslipidemia. Relative CASR transcript was lower at a borderline significance level in patients harboring the rs1801725 variant allele compared with homozygotes of the major allele (0.20, 0.06-7.80 vs. 0.43, 0.04-5.06, P = 0.058). CASR transcript correlated positively with RXRA transcript (adjusted P = 0.001), LXRA transcript (adjusted P = 0.0009), ENHO transcript (borderline significance, adjusted P = 0.055), dry body weight (adjusted P = 0.035), and renal replacement therapy duration (adjusted P = 0.013).Conclusions: CASR polymorphisms (rs7652589, rs1801725) are associated with dyslipidemia in HD patients. CASR correlates with RXRA, LXRA, and ENHO at the transcript level. Further investigations may elucidate whether other CASR SNPs contribute to associations shown in this study.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N